Pouessel G, Deschildre A, Castelain C, Sardet A, Sagot-Bevenot S, de Sauve-Boeuf A, Thumerelle C, Santos C
Unité de pneumologie-allergologie pédiatrique, Clinique de Pédiatrie, Hôpital Jeanne de Flandre, CHRU de Lille, France.
Pediatr Allergy Immunol. 2006 May;17(3):221-6. doi: 10.1111/j.1399-3038.2006.00391.x.
Epinephrine should be prescribed for patients at risk of anaphylaxis. Our purpose was to determine the use of Anapen prescribed for food-allergic children, to assess parental knowledge regarding Anapen, and to evaluate the arrangements for emergency kits and personalized care projects in everyday life. A prospective study was performed with a questionnaire sent to families with a food-allergic child previously prescribed Anapen. One hundred and fifty two families were contacted and finally 111 children included (median age 6.5 yrs). Main food allergens were peanuts (n = 89), egg (n = 39) and cow's milk (n = 10). The use of Anapen had been demonstrated to 90% of parents (by prescribing physician, 69%; pharmacist, 25%; general practitioner, 5%; nurse 1%), with a training device (76%) and/or written instructions (49%). When asked to list symptoms requiring injection, 48% of parents cited more than one response: breathing difficulties only (23%), or with angio-edema (41%), collapse or faintness (38%), anaphylactic shock (48%). Of 107 children attending school, 54% had a personalized care project, 72% an Anapen device, and 60% a complete emergency kit (epinephrine, inhaled beta-agonist, corticosteroid, anti-H1 drug). Beta-agonists were forgotten at school by 34 children (13 asthmatics). Anapen was used in one child for angio-edema and dyspnea after inadvertent ingestion of egg at home. In our population, epinephrine auto-injectors and emergency kits were insufficiently available at schools and in daily life. The use of auto-injectors was not adequately demonstrated. The prescription of epinephrine for food-allergic children at risk of anaphylaxis requires accurate diagnosis, educational programs, information, and follow up.
对于有过敏反应风险的患者,应开具肾上腺素处方。我们的目的是确定为食物过敏儿童开具的安纳芬(Anapen)的使用情况,评估家长对安纳芬的了解程度,并评估日常生活中急救包和个性化护理项目的安排。我们进行了一项前瞻性研究,向之前为孩子开具过安纳芬的食物过敏儿童家庭发送了问卷。我们联系了152个家庭,最终纳入了111名儿童(中位年龄6.5岁)。主要食物过敏原为花生(89例)、鸡蛋(39例)和牛奶(10例)。90%的家长(由开具处方的医生证明的占69%;药剂师证明的占25%;全科医生证明的占5%;护士证明的占1%)了解安纳芬的使用方法,其中76%配有训练装置,49%配有书面说明。当被要求列出需要注射的症状时,48%的家长给出了不止一个答案:仅呼吸困难(23%)、或伴有血管性水肿(41%)、虚脱或昏厥(38%)、过敏性休克(48%)。在107名上学的儿童中,54%有个性化护理项目,72%有安纳芬装置,60%有完整的急救包(肾上腺素、吸入型β受体激动剂、皮质类固醇、抗组胺药H1)。有34名儿童(13名哮喘患者)在学校忘记携带β受体激动剂。有一名儿童在家中意外摄入鸡蛋后出现血管性水肿和呼吸困难,使用了安纳芬。在我们的研究人群中,学校和日常生活中肾上腺素自动注射器和急救包的配备不足。自动注射器的使用方法没有得到充分说明。为有过敏反应风险的食物过敏儿童开具肾上腺素处方需要准确的诊断、教育项目、信息告知和随访。